BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30327468)

  • 1. A shear-dependent NO-cGMP-cGKI cascade in platelets acts as an auto-regulatory brake of thrombosis.
    Wen L; Feil S; Wolters M; Thunemann M; Regler F; Schmidt K; Friebe A; Olbrich M; Langer H; Gawaz M; de Wit C; Feil R
    Nat Commun; 2018 Oct; 9(1):4301. PubMed ID: 30327468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NO/cGMP pathway inhibits Rap 1 activation in human platelets via cGMP-dependent protein kinase I.
    Danielewski O; Schultess J; Smolenski A
    Thromb Haemost; 2005 Feb; 93(2):319-25. PubMed ID: 15711749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation.
    Antl M; von Brühl ML; Eiglsperger C; Werner M; Konrad I; Kocher T; Wilm M; Hofmann F; Massberg S; Schlossmann J
    Blood; 2007 Jan; 109(2):552-9. PubMed ID: 16990611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic GMP-Dependent Regulation of Vascular Tone and Blood Pressure Involves Cysteine-Rich LIM-Only Protein 4 (CRP4).
    Längst N; Adler J; Schweigert O; Kleusberg F; Cruz Santos M; Knauer A; Sausbier M; Zeller T; Ruth P; Lukowski R
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombocytosis as a response to high interleukin-6 levels in cGMP-dependent protein kinase I mutant mice.
    Zhang L; Lukowski R; Gaertner F; Lorenz M; Legate KR; Domes K; Angermeier E; Hofmann F; Massberg S
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1820-8. PubMed ID: 23788765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the NO-GC/cGMP signaling pathway in platelet biomechanics.
    Balmes A; Rodríguez JG; Seifert J; Pinto-Quintero D; Khawaja AA; Boffito M; Frye M; Friebe A; Emerson M; Seta F; Feil R; Feil S; Schäffer TE
    Platelets; 2024 Dec; 35(1):2313359. PubMed ID: 38353233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic peptide-mediated inhibition of microcirculatory endothelial Ca2+ and permeability response to histamine involves cGMP-dependent protein kinase I and TRPC6 channels.
    Chen W; Oberwinkler H; Werner F; Gaßner B; Nakagawa H; Feil R; Hofmann F; Schlossmann J; Dietrich A; Gudermann T; Nishida M; Del Galdo S; Wieland T; Kuhn M
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2121-9. PubMed ID: 23814119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling.
    Mullershausen F; Friebe A; Feil R; Thompson WJ; Hofmann F; Koesling D
    J Cell Biol; 2003 Mar; 160(5):719-27. PubMed ID: 12604588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of platelet guanylyl cyclase by collagen: evidence that Glycoprotein VI mediates platelet nitric oxide synthesis in response to collagen.
    Riba R; Sharifi M; Farndale RW; Naseem KM
    Thromb Haemost; 2005 Aug; 94(2):395-403. PubMed ID: 16113831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NO/cGMP/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders.
    Degjoni A; Campolo F; Stefanini L; Venneri MA
    J Thromb Haemost; 2022 Nov; 20(11):2465-2474. PubMed ID: 35950928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase.
    Rukoyatkina N; Walter U; Friebe A; Gambaryan S
    Thromb Haemost; 2011 Nov; 106(5):922-33. PubMed ID: 21800013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targets of cGMP/cGKI in Cardiac Myocytes.
    Adler J; Kuret A; Längst N; Lukowski R
    J Cardiovasc Pharmacol; 2020 Jun; 75(6):494-507. PubMed ID: 32168155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation.
    Schinner E; Salb K; Schlossmann J
    Platelets; 2011; 22(3):217-27. PubMed ID: 21244222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the Na(+)-K(+)-2Cl(-) cotransporter by cGMP/cGMP-dependent protein kinase I after furosemide administration.
    Limmer F; Schinner E; Castrop H; Vitzthum H; Hofmann F; Schlossmann J
    FEBS J; 2015 Oct; 282(19):3786-98. PubMed ID: 26183401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical Modelling of Nitric Oxide/Cyclic GMP/Cyclic AMP Signalling in Platelets.
    Kleppe R; Jonassen I; Døskeland SO; Selheim F
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-Time Imaging Reveals Augmentation of Glutamate-Induced Ca
    Paolillo M; Peters S; Schramm A; Schlossmann J; Feil R
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30049956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the NO/soluble guanylate cyclase/cGMP system on the functions of human platelets.
    Makhoul S; Walter E; Pagel O; Walter U; Sickmann A; Gambaryan S; Smolenski A; Zahedi RP; Jurk K
    Nitric Oxide; 2018 Jun; 76():71-80. PubMed ID: 29550521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signaling pathway in stimulating platelet secretion and aggregation.
    Stojanovic A; Marjanovic JA; Brovkovych VM; Peng X; Hay N; Skidgel RA; Du X
    J Biol Chem; 2006 Jun; 281(24):16333-9. PubMed ID: 16613861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cGMP and cGMP-dependent protein kinase in platelets and blood cells.
    Walter U; Gambaryan S
    Handb Exp Pharmacol; 2009; (191):533-48. PubMed ID: 19089344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H₂O₂ lowers the cytosolic Ca²⁺ concentration via activation of cGMP-dependent protein kinase Iα.
    Müller PM; Gnügge R; Dhayade S; Thunemann M; Krippeit-Drews P; Drews G; Feil R
    Free Radic Biol Med; 2012 Oct; 53(8):1574-83. PubMed ID: 22922339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.